Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04036188 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis

StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv11
  2. Primary and study completion dates: Dec 2024 to Dec 2026v10
  3. Primary and study completion dates: Aug 2024 to Dec 2024v9
  4. Re-verified, no change to tracked fieldsv8
  5. Primary and study completion dates: Aug 2022 to Aug 2024v7
Show 5 earlier versionsHide 5 earlier versions
  1. Lead sponsor: Wright State Physicians to Wright State University
    • Eligibility criteria expanded, about 1 word
    v6
  2. Primary completion date: Aug 2021 to Aug 2022v5
  3. Primary completion date: Aug 2020 to Aug 2021v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 2019 to Oct 16, 2019
    • Site details revised
    v3
  5. Start date: Aug 2019 to Oct 2019v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
These studies are designed to assess the synergistic efficacy of topical 0.1% triamcinolone cream paired with 40,000 IU of oral vitamin D3 daily in treating mild to moderate psoriasis. The study is designed to have all subjects treated with triamcinolone cream (TAC) for 4 weeks, then will be randomized 1:1 into vitamin D3 or placebo for an additional 12 weeks. At that time, the study will become open-label and all subjects will be placed on (or continue) vitamin D3 for an additional 12 weeks. The study will take place over 28 weeks total.
Trial Details
NCT Number NCT04036188
Lead Sponsor Wright State University
Conditions
(from sponsor)		 Plaque Psoriasis, Vitamin D3
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov